NLRP3 and metabolic dysfunction-associated steatohepatitis: Our data indicated that in a mouse model of NASH with deletion of TGR5, the NLRP3 inflammasome was significantly increased, suggesting that TGR5 attenuated inflammation in NASH by inhibiting activation of NLPR3.